Skip to main content
. 2018 May 30;25(9):R467–R478. doi: 10.1530/ERC-18-0068

Table 2.

Number and percentage of patients pertaining to each subtype with an alteration in the specified spliceosome component genes.

SF3B1 SF3B3 SRSF1 SRSF2 SRSF3 SRSF4 RBFOX2 ESRP1 RBM47 LIN28A
Basaln = 391 12 (3.07) 10 (2.56) 11 (2.81) 22 (5.63) 15 (3.84) 6 (1.53) 5 (1.28) 84 (21.48) 13 (3.32) 1 (0.26)
Her2n = 287 9 (3.14) 3 (1.05) 39 (13.59) 25 (8.71) 2 (0.70) 1 (0.35) 2 (0.70) 99 (34.49) 6 (2.09) 1 (0.35)
Luminal An = 909 40 (4.40) 17 (1.87) 31 (3.41) 26 (2.86) 5 (0.55) 2 (0.22) 2 (0.22) 103 (11.33) 5 (0.55) 3 (0.33)
Luminal Bn = 590 19 (3.22) 5 (0.85) 99 (16.78) 50 (8.47) 3 (0.51) 2 (0.34) 4 (0.68) 159 (26.95) 2 (0.34) 1 (0.17)
Normal liken = 179 4 (2.23) 3 (1.68) 10 (5.59) 7 (3.91) 0 (0.00) 1 (0.56) 0 (0.00) 23 (12.85) 1 (0.56) 0 (0.00)

Data were derived from METABRIC and TCGA samples with available PAM50 subtype scores (n = 2363). Percentages in brackets.